Cilium, centrosome and cell cycle regulation in polycystic kidney disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 10, 2011, Pages 1263-1271

  Lee, Kyung ^a   Battini, Lorenzo ^a   Gusella, G Luca ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Centrosome; Cilium; Cystogenesis; Kidney; Planar cell polarity

Indexed keywords

B RAF KINASE; CALCIUM ION; CYCLIC AMP; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROCYSTIN; JANUS KINASE 2; KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; OCTREOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYCYSTIN 1; POLYCYSTIN 2; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN; SOMATOSTATIN; STAT6 PROTEIN; TUBERIN; VASCULOTROPIN RECEPTOR; WNT PROTEIN; WNT9B PROTEIN;

AXONEME; CANCER CELL; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CELL GROWTH; CELL METABOLISM; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CENTROSOME; CYTOSKELETON; DISEASE COURSE; EUKARYOTIC FLAGELLUM; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MICROTUBULE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; UNSPECIFIED SIDE EFFECT; WILD TYPE;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CENTROSOME; CILIA; HUMANS; MICE; MODELS, BIOLOGICAL; POLYCYSTIC KIDNEY DISEASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRPP CATION CHANNELS;

EID: 80052270551     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.02.008     Document Type: Review

References (150)

1. Bisceglia M., Galliani C.A., Senger C., Stallone C., Sessa A. Renal cystic diseases: a review. Adv. Anat. Pathol. 2006, 13:26-56.
2. Onuchic L.F., Furu L., Nagasawa Y., Hou X., Eggermann T., Ren Z., Bergmann C., Senderek J., Esquivel E., Zeltner R., Rudnik-Schöneborn S., Mrug M., Sweeney W., Avner E.D., Zerres K., Guay-Woodford L.M., Somlo S., Germino G.G. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am. J. Hum. Genet. 2002, 70:1305-1317.
3. Ward C.J., Hogan M.C., Rossetti S., Walker D., Sneddon T., Wang X., Kubly V., Cunningham J.M., Bacallao R., Ishibashi M., Milliner D.S., Torres V.E., Harris P.C. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 2002, 30:259-269.
4. Malhas A.N., Abuknesha R.A., Price R.G. Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation. J. Am. Soc. Nephrol. 2002, 13:19-26.
5. Qian F., Boletta A., Bhunia A.K., Xu H., Liu L., Ahrabi A.K., Watnick T.J., Zhou F., Germino G.G. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc. Natl Acad. Sci. USA 2002, 99:16981-16986.
6. Wei W., Hackmann K., Xu H., Germino G., Qian F. Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene. J. Biol. Chem. 2007, 282:21729-21737.
7. Wilson P.D. Polycystin: new aspects of structure, function, and regulation. J. Am. Soc. Nephrol. 2001, 12:834-845.
8. Parnell S., Magenheimer B., Maser R., Rankin C., Smine A., Okamoto T., Calvet J. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem. Biophys. Res. Commun. 1998, 251:625-631.
9. Parnell S.C., Magenheimer B.S., Maser R.L., Zien C.A., Frischauf A.-M., Calvet J.P. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J. Biol. Chem. 2002, 277:19566-19572.
10. Chauvet V., Tian X., Husson H., Grimm D.H., Wang T., Hiesberger T., Hieseberger T., Igarashi P., Bennett A.M., Ibraghimov-Beskrovnaya O., Somlo S., Caplan M.J. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J. Clin. Invest. 2004, 114:1433-1443.
11. Cai Y., Maeda Y., Cedzich A., Torres V.E., Wu G., Hayashi T., Mochizuki T., Park J.H., Witzgall R., Somlo S. Identification and characterization of polycystin-2, the PKD2 gene product. J. Biol. Chem. 1999, 274:28557-28565.
12. Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R., Ehrlich B.E., Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 2002, 4:191-197.
13. Alenghat F.J., Nauli S.M., Kolb R., Zhou J., Ingber D.E. Global cytoskeletal control of mechanotransduction in kidney epithelial cells. Exp. Cell Res. 2004, 301:23-30.
14. Köttgen M. TRPP2 and autosomal dominant polycystic kidney disease. Biochim. Biophys. Acta 2007, 1772:836-850.
15. Tsiokas L., Kim S., Ong E.-C. Cell biology of polycystin-2. Cell. Signal. 2007, 19:444-453.
16. Scheffers M.S., Le H., van der Bent P., Leonhard W., Prins F., Spruit L., Breuning M.H., de Heer E., Peters D.J.M. Distinct subcellular expression of endogenous polycystin-2 in the plasma membrane and Golgi apparatus of MDCK cells. Hum. Mol. Genet. 2002, 11:59-67.
17. Luo Y., Vassilev P.M., Li X., Kawanabe Y., Zhou J. Native polycystin 2 functions as a plasma membrane Ca2+-permeable cation channel in renal epithelia. Mol. Cell. Biol. 2003, 23:2600-2607.
18. Karcher C., Fischer A., Schweickert A., Bitzer E., Horie S., Witzgall R., Blum M. Lack of a laterality phenotype in Pkd1 knock-out embryos correlates with absence of polycystin-1 in nodal cilia. Differentiation 2005, 73:425-432.
19. Sharif-Naeini R., Folgering J.H.A., Bichet D., Duprat F., Lauritzen I., Arhatte M., Jodar M., Dedman A., Chatelain F.C., Schulte U., Retailleau K., Loufrani L., Patel A., Sachs F., Delmas P., Peters D.J.M., Honoré E. Polycystin-1 and -2 dosage regulates pressure sensing. Cell 2009, 139:587-596.
20. Tsiokas L. Function and regulation of TRPP2 at the plasma membrane. Am. J. Physiol. Ren. Physiol. 2009, 297:F1-F9.
21. Chen X.-Z., Li Q., Wu Y., Liang G., Lara C.J., Cantiello H.F. Submembraneous microtubule cytoskeleton: interaction of TRPP2 with the cell cytoskeleton. FEBS J. 2008, 275:4675-4683.
22. Huan Y., van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J. Clin. Invest. 1999, 104:1459-1468.
23. Geng L., Burrow C., Li H., Wilson P. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim. Biophys. Acta 2000, 1535:21-35.
24. Boca M., D'Amato L., Distefano G., Polishchuk R., Germino G., Boletta A. Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell-cell mechanical adhesion. Mol. Biol. Cell 2007, 18:4050-4061.
25. Gao H., Sellin L.K., Pütz M., Nickel C., Imgrund M., Gerke P., Nitschke R., Walz G., Kramer-Zucker A.G. A short carboxy-terminal domain of polycystin-1 reorganizes the microtubular network and the endoplasmic reticulum. Exp. Cell Res. 2009, 315:1157-1170.
26. Hiesberger T., Gourley E., Erickson A., Koulen P., Ward C.J., Masyuk T.V., Larusso N.F., Harris P.C., Igarashi P. Proteolytic cleavage and nuclear translocation of fibrocystin is regulated by intracellular Ca2+ and activation of protein kinase C. J. Biol. Chem. 2006, 281:34357-34364.
27. Kaimori J.-Y., Nagasawa Y., Menezes L.F., Garcia-Gonzalez M.A., Deng J., Imai E., Onuchic L.F., Guay-Woodford L.M., Germino G.G. Polyductin undergoes notch-like processing and regulated release from primary cilia. Hum. Mol. Genet. 2007, 16:942-956.
28. Torres V.E., Harris P.C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 2009, 76:149-168.
29. Harris P.C. 2008 Homer W. Smith Award insights into pathogenesis polycystic kidney disease gene discovery. J Am Soc Nephrol 2009, 20:1188-1198.
30. Zhou J. Polycystins and primary cilia: primers for cell cycle progression. Annu. Rev. Physiol. 2009, 71:83-113.
31. Chapin H.C., Caplan M.J. The cell biology of polycystic kidney disease. J. Cell Biol. 2010, 191:701-710.
32. Grantham J., Torres V., Chapman A., Guay-Woodford L., Bae K., King B., Wetzel L., Baumgarten D., Kenney P., Harris P., Klahr S., Bennett W., Hirschman G., Meyers C., Zhang X., Zhu F., Miller J. Volume progression in polycystic kidney disease. N. Engl. J. Med. 2006, 354:2122-2130.
33. Grantham J.J., Chapman A.B., Torres V.E. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin. journal Am. Soc. Nephrol. CJASN 2006, 1:148-157.
34. Nadasdy T., Laszik Z., Lajoie G., Blick K.E., Wheeler D.E., Silva F.G. Proliferative activity of cyst epithelium in human renal cystic diseases. J. Am. Soc. Nephrol. 1995, 5:1462-1468.
35. Chang M.Y., Parker E., Ibrahim S., Shortland J.R., Nahas M.E., Haylor J.L., Ong A.C.M. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol. Dial. Transplant. 2006, 21:2078-2084.
36. Takakura A., Contrino L., Zhou X., Bonventre J.V., Sun Y., Humphreys B.D., Zhou J. Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum. Mol. Genet. 2009, 18:2523-2531.
37. Delmas P., Nomura H., Li X., Lakkis M., Luo Y., Segal Y., Fernández-Fernández J.M., Harris P., Frischauf A.-M., Brown D.A., Zhou J. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J. Biol. Chem. 2002, 277:11276-11283.
38. Wang X., Ward C.J., Harris P.C., Torres V.E. Cyclic nucleotide signaling in polycystic kidney disease. Kidney Int. 2010, 77:129-140.
39. Mangoo-Karim R., Uchic M., Lechene C., Grantham J.J. Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc. Natl Acad. Sci. USA 1989, 86:6007-6011.
40. Hanaoka K., Guggino W.B. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J. Am. Soc. Nephrol. 2000, 11:1179-1187.
41. Yamaguchi T., Nagao S., Wallace D.P., Belibi F.A., Cowley B.D., Pelling J.C., Grantham J.J. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int. 2003, 63:1983-1994.
42. Sutters M., Yamaguchi T., Maser R.L., Magenheimer B.S., St John P.L., Abrahamson D.R., Grantham J.J., Calvet J.P. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. Kidney Int. 2001, 60:484-494.
43. Belibi F.A., Reif G., Wallace D.P., Yamaguchi T., Olsen L., Li H., Helmkamp G.M., Grantham J.J. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004, 66:964-973.
44. Montesano R., Ghzili H., Carrozzino F., Rossier B.C., Féraille E. cAMP-dependent chloride secretion mediates tubule enlargement and cyst formation by cultured mammalian collecting duct cells. Am. J. Physiol. Ren. Physiol. 2009, 296:F446-F457.
45. Cai Y., Anyatonwu G., Okuhara D., Lee K.-B., Yu Z., Onoe T., Mei C.-L., Qian Q., Geng L., Wiztgall R., Ehrlich B.E., Somlo S. Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J. Biol. Chem. 2004, 279:19987-19995.
46. Du J., Wilson P.D. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am. J. Physiol. 1995, 269:C487-C495.
47. Orellana S.A., Sweeney W.E., Neff C.D., Avner E.D. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int. 1995, 47:490-499.
48. Wilson S., Amsler K., Hyink D., Li X., Lu W., Zhou J., Burrow C., Wilson P. Inhibition of HER-2(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim. Biophys. Acta 2006, 1762:647-655.
49. Sweeney W.E., Futey L., Frost P., Avner E.D. In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor. Kidney Int. 1999, 56:406-413.
50. Sweeney W., Hamahira K., Sweeney J., Garcia-Gatrell M., Frost P., Avner E. Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Kidney Int. 2003, 64:1310-1319.
51. Sweeney W.E., Chen Y., Nakanishi K., Frost P., Avner E.D. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int. 2000, 57:33-40.
52. Torres V., Sweeney W., Wang X., Qian Q., Harris P., Frost P., Avner E. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int. 2003, 64:1573-1579.
53. Torres V., Sweeney W., Wang X., Qian Q., Harris P., Frost P., Avner E. Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats. Kidney Int. 2004, 66:1766-1773.
54. Shillingford J.M., Murcia N.S., Larson C.H., Low S.H., Hedgepeth R., Brown N., Flask C.A., Novick A.C., Goldfarb D.A., Kramer-Zucker A., Walz G., Piontek K.B., Germino G.G., Weimbs T. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 2006, 103:5466-5471.
55. Boletta A. Emerging evidence of a link between the polycystins and the mTOR pathways. PathoGenetics 2009, 2:6.
56. Huang J., Manning B.D. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem. J. 2008, 412:179-190.
57. Foster K.G., Fingar D.C. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J. Biol. Chem. 2010, 285:14071-14077.
58. Gao N., Flynn D.C., Zhang Z., Zhong X.-S., Walker V., Liu K.J., Shi X., Jiang B.-H. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am. J. Physiol. Cell Physiol. 2004, 287:C281-C291.
59. Distefano G., Boca M., Rowe I., Claas W., Ma L., Piontek K., Germino G., Pandolfi P., Boletta A. Polycystin-1 regulates ERKs-dependent phosphorylation of Tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol. Cell. Biol. 2009.
60. Dere R., Wilson P.D., Sandford R.N., Walker C.L. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS ONE 2010, 5:e9239.
61. Kleymenova E., Ibraghimov-Beskrovnaya O., Kugoh H., Everitt J., Xu H., Kiguchi K., Landes G., Harris P., Walker C. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol. Cell 2001, 7:823-832.
62. Meijer E., de Jong P., Peters D., Gansevoort R. Better understanding of ADPKD results in potential new treatment options: ready for the cure?. J. Nephrol. 2008, 21:133-138.
63. Gattone V.H., Chen N.X., Sinders R.M., Seifert M.F., Duan D., Martin D., Henley C., Moe S.M. Calcimimetic inhibits late-stage cyst growth in ADPKD. J. Am. Soc. Nephrol. 2009, 20:1527-1532.
64. Torres V.E., Harris P.C. Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities. J. Intern. Med. 2007, 261:17-31.
65. Chapman A.B. Autosomal dominant polycystic kidney disease: time for a change?. J. Am. Soc. Nephrol. 2007, 18:1399-1407.
66. Shillingford J.M., Piontek K.B., Germino G.G., Weimbs T. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J. Am. Soc. Nephrol. 2010, 21:489-497.
67. Sweeney W.E., von Vigier R.O., Frost P., Avner E.D. Src inhibition ameliorates polycystic kidney disease. J. Am. Soc. Nephrol. 2008, 19:1331-1341.
68. Bukanov N.O., Smith L.A., Klinger K.W., Ledbetter S.R., Ibraghimov-Beskrovnaya O. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 2006, 444:949-952.
69. Torres V.E. Treatment strategies and clinical trial design in ADPKD. Adv. Chron. Kidney Dis. 2010, 17:190-204.
70. Serra A.L., Poster D., Kistler A.D., Krauer F., Raina S., Young J., Rentsch K.M., Spanaus K.S., Senn O., Kristanto P., Scheffel H., Weishaupt D., Wüthrich R.P. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 2010, 363:820-829.
71. Walz G., Budde K., Mannaa M., Nürnberger J., Wanner C., Sommerer C., Kunzendorf U., Banas B., Hörl W.H., Obermüller N., Arns W., Pavenstädt H., Gaedeke J., Büchert M., May C., Gschaidmeier H., Kramer S., Eckardt K.-U. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 2010, 363:830-840.
72. Perico N., Antiga L., Caroli A., Ruggenenti P., Fasolini G., Cafaro M., Ondei P., Rubis N., Diadei O., Gherardi G., Prandini S., Panozo A., Bravo R.F., Carminati S., De Leon F.R., Gaspari F., Cortinovis M., Motterlini N., Ene-Iordache B., Remuzzi A., Remuzzi G. Sirolimus therapy to halt the progression of ADPKD. J. Am. Soc. Nephrol. 2010, 21:1031-1040.
73. Watnick T., Germino G.G. mTOR inhibitors in polycystic kidney disease. N. Engl. J. Med. 2010, 363:879-881.
74. Perico N., Remuzzi G. Polycystic kidney disease: do mTOR inhibitors still have a future in ADPKD?. Nat. Rev. Nephrol. 2010, 6:696-698.
75. Hogan M.C., Masyuk T.V., Page L.J., Kubly V.J., Bergstralh E.J., Li X., Kim B., King B.F., Glockner J., Holmes D.R., Rossetti S., Harris P.C., LaRusso N.F., Torres V.E. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J. Am. Soc. Nephrol. 2010, 21:1052-1061.
76. Pazour G.J., Dickert B.L., Vucica Y., Seeley E.S., Rosenbaum J.L., Witman G.B., Cole D.G. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J. Cell Biol. 2000, 151:709-718.
77. Hou X., Mrug M., Yoder B.K., Lefkowitz E.J., Kremmidiotis G., D'Eustachio P., Beier D.R., Guay-Woodford L.M. Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. J. Clin. Invest. 2002, 109:533-540.
78. Yoder B.K., Hou X., Guay-Woodford L.M. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J. Am. Soc. Nephrol. 2002, 13:2508-2516.
79. Badano J.L., Mitsuma N., Beales P.L., Katsanis N. The ciliopathies: an emerging class of human genetic disorders. Annu. Rev. Genomics Hum. Genet. 2006, 7:125-148.
80. Lancaster M.A., Gleeson J.G. The primary cilium as a cellular signaling center: lessons from disease. Curr. Opin. Genet. Dev. 2009, 19:220-229.
81. Baker K., Beales P.L. Making sense of cilia in disease: the human ciliopathies. Am. J. Med. Genet. C Semin. Med. Genet. 2009, 151C:281-295.
82. Deltas C., Papagregoriou G. Cystic diseases of the kidney: molecular biology and genetics. Arch. Pathol. Lab. Med. 2010, 134:569-582.
83. Yoder B.K. Role of primary cilia in the pathogenesis of polycystic kidney disease. J. Am. Soc. Nephrol. 2007, 18:1381-1388.
84. Singla V., Reiter J.F. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science 2006, 313:629-633.
85. Praetorius H.A., Spring K.R. Bending the MDCK cell primary cilium increases intracellular calcium. J. Membr. Biol. 2001, 184:71-79.
86. Nauli S.M., Alenghat F.J., Luo Y., Williams E., Vassilev P., Li X., Elia A.E.H., Lu W., Brown E.M., Quinn S.J., Ingber D.E., Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 2003, 33:129-137.
87. Wang S., Zhang J., Nauli S.M., Li X., Starremans P.G., Luo Y., Roberts K.A., Zhou J. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol. Cell. Biol. 2007, 27:3241-3252.
88. Low S.H., Vasanth S., Larson C.H., Mukherjee S., Sharma N., Kinter M.T., Kane M.E., Obara T., Weimbs T. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev. Cell 2006, 10:57-69.
89. Davenport J.R., Watts A.J., Roper V.C., Croyle M.J., van Groen T., Wyss J.M., Nagy T.R., Kesterson R.A., Yoder B.K. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr. Biol. 2007, 17:1586-1594.
90. Lantinga-van Leeuwen I.S., Leonhard W.N., van der Wal A., Breuning M.H., de Heer E., Peters D.J.M. Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum. Mol. Genet. 2007, 16:3188-3196.
91. Piontek K., Menezes L.F., Garcia-Gonzalez M.A., Huso D.L., Germino G.G. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 2007, 13:1490-1495.
92. Takakura A., Contrino L., Beck A.W., Zhou J. Pkd1 inactivation induced in adulthood produces focal cystic disease. J. Am. Soc. Nephrol. 2008, 19:2351-2363.
93. Patel V., Li L., Cobo-Stark P., Shao X., Somlo S., Lin F., Igarashi P. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 2008, 17:1578-1590.
94. Happé H., Leonhard W.N., van der Wal A., van de Water B., Lantinga-van Leeuwen I.S., Breuning M.H., de Heer E., Peters D.J.M. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum. Mol. Genet. 2009, 18:2532-2542.
95. Verdeguer F., Le Corre S., Fischer E., Callens C., Garbay S., Doyen A., Igarashi P., Terzi F., Pontoglio M. A mitotic transcriptional switch in polycystic kidney disease. Nat. Med. 2010, 16:106-110.
96. Klein T.J., Mlodzik M. Planar cell polarization: an emerging model points in the right direction. Annu. Rev. Cell Dev. Biol. 2005, 21:155-176.
97. Lancaster M.A., Louie C.M., Silhavy J.L., Sintasath L., Decambre M., Nigam S.K., Willert K., Gleeson J.G. Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat. Med. 2009, 15:1046-1054.
98. Simons M., Gloy J., Ganner A., Bullerkotte A., Bashkurov M., Krönig C., Schermer B., Benzing T., Cabello O.A., Jenny A., Mlodzik M., Polok B., Driever W., Obara T., Walz G. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 2005, 37:537-543.
99. Gresh L., Fischer E., Reimann A., Tanguy M., Garbay S., Shao X., Hiesberger T., Fiette L., Igarashi P., Yaniv M., Pontoglio M. A transcriptional network in polycystic kidney disease. EMBO J. 2004, 23:1657-1668.
100. Masyuk T.V., Huang B.Q., Masyuk A.I., Ritman E.L., Torres V.E., Wang X., Harris P.C., LaRusso N.F. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease. Am. J. Pathol. 2004, 165:1719-1730.
101. Fischer E., Legue E., Doyen A., Nato F., Nicolas J.-F., Torres V., Yaniv M., Pontoglio M. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 2006, 38:21-23.
102. Saburi S., Hester I., Fischer E., Pontoglio M., Eremina V., Gessler M., Quaggin S.E., Harrison R., Mount R., McNeill H. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat. Genet. 2008, 40:1010-1015.
103. Park T.J., Haigo S.L., Wallingford J.B. Ciliogenesis defects in embryos lacking inturned or fuzzy function are associated with failure of planar cell polarity and Hedgehog signaling. Nat. Genet. 2006, 38:303-311.
104. Borovina A., Superina S., Voskas D., Ciruna B. Vangl2 directs the posterior tilting and asymmetric localization of motile primary cilia. Nat. Cell Biol. 2010, 12:407-412.
105. Kotsis F., Nitschke R., Doerken M., Walz G., Kuehn E.W. Flow modulates centriole movements in tubular epithelial cells. Pflugers Arch 2008, 456:1025-1035.
106. Guirao B., Meunier A., Mortaud S., Aguilar A., Corsi J.-M., Strehl L., Hirota Y., Desoeuvre A., Boutin C., Han Y.-G., Mirzadeh Z., Cremer H., Montcouquiol M., Sawamoto K., Spassky N. Coupling between hydrodynamic forces and planar cell polarity orients mammalian motile cilia. Nat. Cell Biol. 2010, 12:341-350.
107. Karner C.M., Chirumamilla R., Aoki S., Igarashi P., Wallingford J.B., Carroll T.J. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat. Genet. 2009, 41:793-799.
108. Nishio S., Tian X., Gallagher A.R., Yu Z., Patel V., Igarashi P., Somlo S. Loss of oriented cell division does not initiate cyst formation. J. Am. Soc. Nephrol. 2009.
109. Pedersen L.B., Rosenbaum J.L. Intraflagellar transport (IFT) role in ciliary assembly, resorption and signalling. Curr. Top. Dev. Biol. 2008, 85:23-61.
110. Gerdes J.M., Liu Y., Zaghloul N.A., Leitch C.C., Lawson S.S., Kato M., Beachy P.A., Beales P.L., DeMartino G.N., Fisher S., Badano J.L., Katsanis N. Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response. Nat. Genet. 2007, 39:1350-1360.
111. Doxsey S., Zimmerman W., Mikule K. Centrosome control of the cell cycle. Trends Cell Biol. 2005, 15:303-311.
112. Hoffmann I. Linking the cell cycle to the centrosome cycle 2005.
113. Meraldi P., Nigg E. The centrosome cycle. FEBS Lett. 2002, 521:9-13.
114. Follit J.A., Tuft R.A., Fogarty K.E., Pazour G.J. The intraflagellar transport protein IFT20 is associated with the Golgi complex and is required for cilia assembly. Mol. Biol. Cell 2006, 17:3781-3792.
115. Jurczyk A., Gromley A., Redick S., San Agustin J., Witman G., Pazour G.J., Peters D.J.M., Doxsey S. Pericentrin forms a complex with intraflagellar transport proteins and polycystin-2 and is required for primary cilia assembly. J. Cell Biol. 2004, 166:637-643.
116. Robert A., Margall-Ducos G., Guidotti J.-E., Brégerie O., Celati C., Bréchot C., Desdouets C. The intraflagellar transport component IFT88/polaris is a centrosomal protein regulating G1-S transition in non-ciliated cells. J. Cell Sci. 2007, 120:628-637.
117. Srsen V., Gnadt N., Dammermann A., Merdes A. Inhibition of centrosome protein assembly leads to p53-dependent exit from the cell cycle. J. Cell Biol. 2006, 174:625-630.
118. Mikule K., Delaval B., Kaldis P., Jurcyzk A., Hergert P., Doxsey S. Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest. Nat. Cell Biol. 2007, 9:160-170.
119. Fukasawa K., Choi T., Kuriyama R., Rulong S., Vande Woude G. Abnormal centrosome amplification in the absence of p53. Science 1996, 271:1744-1747.
120. Tarapore P., Fukasawa K. Loss of p53 and centrosome hyperamplification. Oncogene 2002, 21:6234-6240.
121. Tarapore P., Horn H., Tokuyama Y., Fukasawa K. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene 2001, 20:3173-3184.
122. Shinmura K., Bennett R., Tarapore P., Fukasawa K. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication. Oncogene 2007, 26:2939-2944.
123. Bhunia A., Piontek K., Boletta A., Liu L., Qian F., Xu P., Germino F., Germino G. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002, 109:157-168.
124. Li X., Luo Y., Starremans P.G., McNamara C.A., Pei Y., Zhou J. Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat. Cell Biol. 2005, 7:1202-1212.
125. Kim H., Bae Y., Jeong W., Ahn C., Kang S. Depletion of PKD1 by an antisense oligodeoxynucleotide induces premature G1/S-phase transition. Eur. J. Hum. Genet. 2004, 12:433-440.
126. Battini L., Fedorova E., Macip S., Li X., Wilson P.D., Gusella G.L. Stable knockdown of polycystin-1 confers integrin-α2β1-mediated anoikis resistance. J. Am. Soc. Nephrol. 2006, 17:3049-3058.
127. Nishio S., Hatano M., Nagata M., Horie S., Koike T., Tokuhisa T., Mochizuki T. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J. Clin. Invest. 2005, 115:910-918.
128. Battini L., Macip S., Fedorova E., Dikman S., Somlo S., Montagna C., Gusella G.L. Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum. Mol. Genet. 2008, 17:2819-2833.
129. Castedo M., Perfettini J., Roumier T., Andreau K., Medema R., Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004, 23:2825-2837.
130. Castedo M., Perfettini J., Roumier T., Valent A., Raslova H., Yakushijin K., Horne D., Feunteun J., Lenoir G., Medema R., Vainchenker W., Kroemer G. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 2004, 23:4362-4370.
131. Burtey S., Riera M., Ribe E., Pennenkamp P., Rance R., Luciani J., Dworniczak B., Mattei M.G., Fontés M. Centrosome overduplication and mitotic instability in PKD2 transgenic lines. Cell Biol. Int. 2008, 32:1193-1198.
132. Zhang J., Wu M., Wang S., Shah J., Wilson P.D., Zhou J. Polycystic kidney disease protein fibrocystin localizes to the mitotic spindle and regulates spindle bipolarity. Hum. Mol. Genet. 2010.
133. Rundle D.R., Gorbsky G., Tsiokas L. PKD2 interacts and co-localizes with mDia1 to mitotic spindles of dividing cells: role of mDia1 IN PKD2 localization to mitotic spindles. J. Biol. Chem. 2004, 279:29728-29739.
134. Palazzo A.F., Cook T.A., Alberts A.S., Gundersen G.G. mDia mediates Rho-regulated formation and orientation of stable microtubules. Nat. Cell Biol. 2001, 3:723-729.
135. Li Q., Montalbetti N., Shen P.Y., Dai X.-Q., Cheeseman C.I., Karpinski E., Wu G., Cantiello H.F., Chen X.-Z. Alpha-actinin associates with polycystin-2 and regulates its channel activity. Hum. Mol. Genet. 2005, 14:1587-1603.
136. Li Q., Montalbetti N., Wu Y., Ramos A., Raychowdhury M.K., Chen X.-Z., Cantiello H.F. Polycystin-2 cation channel function is under the control of microtubular structures in primary cilia of renal epithelial cells. J. Biol. Chem. 2006, 281:37566-37575.
137. Hanaoka K., Qian F., Boletta A., Bhunia A., Piontek K., Tsiokas L., Sukhatme V., Guggino W., Germino G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000, 408:990-994.
138. De Boer L., Oakes V., Beamish H., Giles N., Stevens F., Somodevilla-Torres M., Desouza C., Gabrielli B. Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene 2008, 27:4261-4268.
139. Mitsuyama F., Sawai T. The redistribution of Ca2+ stores with inositol 1,4,5-trisphosphate receptor to the cleavage furrow in a microtubule-dependent manner. Int. J. Dev. Biol. 2001, 45:861-868.
140. Matsumoto Y., Maller J.L. Calcium, calmodulin, and CaMKII requirement for initiation of centrosome duplication in Xenopus egg extracts. Science 2002, 295:499-502.
141. Qian Q., Li M., Cai Y., Ward C., Somlo S., Harris P., Torres V. Analysis of the polycystins in aortic vascular smooth muscle cells. J. Am. Soc. Nephrol. 2003, 14:2280-2287.
142. Anyatonwu G.I., Estrada M., Tian X., Somlo S., Ehrlich B.E. Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. Proc. Natl Acad. Sci. USA 2007, 104:6454-6459.
143. Aguiari G., Trimi V., Bogo M., Mangolini A., Szabadkai G., Pinton P., Witzgall R., Harris P.C., Borea P.A., Rizzuto R., del Senno L. Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells. Cell Prolif. 2008, 41:554-573.
144. Uhlén P., Fritz N. Biochemistry of calcium oscillations. Biochem. Biophys. Res. Commun. 2010, 396:28-32.
145. Astrinidis A., Senapedis W., Henske E.P. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner. Hum. Mol. Genet. 2006, 15:287-297.
146. Tammachote R., Hommerding C.J., Sinders R.M., Miller C.A., Czarnecki P.G., Leightner A.C., Salisbury J.L., Ward C.J., Torres V.E., Gattone V.H., Harris P.C. Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3. Hum. Mol. Genet. 2009, 18:3311-3323.
147. Jonassen J.A., San Agustin J., Follit J.A., Pazour G.J. Deletion of IFT20 in the mouse kidney causes misorientation of the mitotic spindle and cystic kidney disease. J. Cell Biol. 2008, 183:377-384.
148. Brasier J.L., Henske E.P. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J. Clin. Invest. 1997, 99:194-199.
149. Gogusev J., Murakami I., Doussau M., Telvi L., Stojkoski A., Lesavre P., Droz D. Molecular cytogenetic aberrations in autosomal dominant polycystic kidney disease tissue. J. Am. Soc. Nephrol. 2003, 14:359-366.
150. Marshall W.F. Basal bodies platforms for building cilia. Curr. Top. Dev. Biol. 2008, 85:1-22.